DiscoverThe ExcerptSPECIAL | Why Americans are making homegrown GLP-1s
SPECIAL | Why Americans are making homegrown GLP-1s

SPECIAL | Why Americans are making homegrown GLP-1s

Update: 2025-10-15
Share

Description

High costs. Limited supply. No insurance coverage. All of these are motivating some patients to cook up unregulated “gray GLP-1” drugs at home. Health experts are worried. Why are people willing to risk injecting homemade drugs in an unregulated, non-sterile medical environment and what needs to change before access and safety improve? USA TODAY Wellness Reporter Nicole Fallert joins The Excerpt to share her reporting on this alarming trend.

Have feedback on the show? Please send us an email at podcasts@usatoday.com

Episode transcript available here


See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

SPECIAL | Why Americans are making homegrown GLP-1s

SPECIAL | Why Americans are making homegrown GLP-1s